Recombinant Adenoviral Vectors Can Induce Expression of P73 Via the E4-orf6/7 Protein

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2006 May 16

PMID 16699015

Citations 4

Authors

Gary S Shapiro

Crystal Van Peursem

David A Ornelles

Jerome Schaack

James DeGregori

Affiliations

Soon will be listed here.

Abstract

Despite the utility of recombinant adenoviral vectors in basic research, their therapeutic promise remains unfulfilled. Most engineered adenoviral vectors use a heterologous promoter to transcribe a foreign gene. We show that adenoviruses containing the cytomegalovirus immediate-early promoter induce the expression of the proapoptotic cellular protein TAp73 via the cyclin-dependent kinase-retinoblastoma protein-E2F pathway in murine embryonic fibroblasts. Cells transduced with these vectors also expressed high levels of the adenoviral E4-orf6/7 and E2A proteins. By contrast, adenoviruses containing the ubiquitin C promoter failed to elicit these effects. E4-orf6/7 is necessary and sufficient for increased TAp73 expression, as shown by using retrovirus-mediated E4-orf6/7 expression and adenovirus with the E4-orf6/7 gene deleted. Activation of TAp73 likely occurs via E4-orf6/7-induced dimerization of E2F and subsequent binding to the inverted E2F-responsive elements within the TAp73 promoter. In addition, adenoviral vectors containing the cytomegalovirus immediate-early promoter, but not the ubiquitin C promoter, cooperated with chemotherapeutic agents to decrease cellularity in vitro. In contrast to murine embryonic fibroblasts, adenoviruses containing the ubiquitin C promoter, but not the cytomegalovirus immediate-early promoter, induced both E4-orf6/7 and TAp73 in human foreskin fibroblasts, emphasizing the importance of cellular context for promoter-dependent effects. Because TAp73 is important for the efficacy of chemotherapy, adenoviruses that increase TAp73 expression may enhance cancer therapies by promoting apoptosis. However, such adenoviruses may impair the long-term survival of transduced cells during gene replacement therapies. Our findings reveal previously unknown effects of foreign promoters in recombinant adenoviral vectors and suggest means to improve the utility of engineered adenoviruses by better controlling their impact on viral and cellular gene expression.

Citing Articles

Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression.

Lamontagne J, Mell J, Bouchard M PLoS Pathog. 2016; 12(2):e1005438.

PMID: 26891448 PMC: 4758756. DOI: 10.1371/journal.ppat.1005438.

Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors.

Schaack J, Bennett M, Shapiro G, DeGregori J, McManaman J, Moorhead J Virology. 2011; 412(1):28-35.

PMID: 21255815 PMC: 4419336. DOI: 10.1016/j.virol.2010.12.054.

Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.

Gregory M, Phang T, Neviani P, Alvarez-Calderon F, Eide C, OHare T Cancer Cell. 2010; 18(1):74-87.

PMID: 20609354 PMC: 2904512. DOI: 10.1016/j.ccr.2010.04.025.

Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.

Burkhart D, Wirt S, Zmoos A, Kareta M, Sage J PLoS Genet. 2010; 6(6):e1001003.

PMID: 20585628 PMC: 2891812. DOI: 10.1371/journal.pgen.1001003.

References

Grimison B, LANGAN T, Sclafani R . P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution. Cell Growth Differ. 2000; 11(10):507-15. View

Leon R, Hedlund T, Meech S, Li S, Schaack J, Hunger S . Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci U S A. 1998; 95(22):13159-64. PMC: 23744. DOI: 10.1073/pnas.95.22.13159. View

Pearson S, Jia H, Kandachi K . China approves first gene therapy. Nat Biotechnol. 2004; 22(1):3-4. PMC: 7097065. DOI: 10.1038/nbt0104-3. View

Schaack J, Bennett M, Colbert J, Torres A, Clayton G, Ornelles D . E1A and E1B proteins inhibit inflammation induced by adenovirus. Proc Natl Acad Sci U S A. 2004; 101(9):3124-9. PMC: 365754. DOI: 10.1073/pnas.0303709101. View

Wan Y, Leon R, Marks R, Cham C, Schaack J, Gajewski T . Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells. Proc Natl Acad Sci U S A. 2000; 97(25):13784-9. PMC: 17653. DOI: 10.1073/pnas.250356297. View

Pozniak C, Radinovic S, Yang A, McKeon F, Kaplan D, Miller F . An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science. 2000; 289(5477):304-6. DOI: 10.1126/science.289.5477.304. View

Flores E, Tsai K, Crowley D, Sengupta S, Yang A, McKeon F . p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 2002; 416(6880):560-4. DOI: 10.1038/416560a. View

Hart L, Yannone S, Naczki C, Orlando J, Waters S, Akman S . The adenovirus E4orf6 protein inhibits DNA double strand break repair and radiosensitizes human tumor cells in an E1B-55K-independent manner. J Biol Chem. 2004; 280(2):1474-81. DOI: 10.1074/jbc.M409934200. View

Yoder S, Berget S . Role of adenovirus type 2 early region 4 in the early-to-late switch during productive infection. J Virol. 1986; 60(2):779-81. PMC: 288957. DOI: 10.1128/JVI.60.2.779-781.1986. View

10.

DeGregori J, Leone G, Miron A, Jakoi L, Nevins J . Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A. 1997; 94(14):7245-50. PMC: 23805. DOI: 10.1073/pnas.94.14.7245. View

11.

Knowles M, Hohneker K, Zhou Z, Olsen J, Noah T, Hu P . A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med. 1995; 333(13):823-31. DOI: 10.1056/NEJM199509283331302. View

12.

Hay J, McElvaney N, Herena J, Crystal R . Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hum Gene Ther. 1995; 6(11):1487-96. DOI: 10.1089/hum.1995.6.11-1487. View

13.

Stevaux O, Dyson N . A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol. 2002; 14(6):684-91. DOI: 10.1016/s0955-0674(02)00388-5. View

14.

Marton M, Baim S, Ornelles D, Shenk T . The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA. J Virol. 1990; 64(5):2345-59. PMC: 249396. DOI: 10.1128/JVI.64.5.2345-2359.1990. View

15.

Shenk T, Jones N, Colby W, Fowlkes D . Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells. Cold Spring Harb Symp Quant Biol. 1980; 44 Pt 1,:367-75. DOI: 10.1101/sqb.1980.044.01.041. View

16.

Meier J, Stinski M . Regulation of human cytomegalovirus immediate-early gene expression. Intervirology. 1996; 39(5-6):331-42. DOI: 10.1159/000150504. View

17.

Pediconi N, Ianari A, Costanzo A, Belloni L, Gallo R, Cimino L . Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat Cell Biol. 2003; 5(6):552-8. DOI: 10.1038/ncb998. View

18.

Weitzman M, Ornelles D . Inactivating intracellular antiviral responses during adenovirus infection. Oncogene. 2005; 24(52):7686-96. DOI: 10.1038/sj.onc.1209063. View

19.

Carson C, Schwartz R, Stracker T, Lilley C, Lee D, Weitzman M . The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 2003; 22(24):6610-20. PMC: 291825. DOI: 10.1093/emboj/cdg630. View

20.

Irwin M, Kondo K, Marin M, Cheng L, Hahn W, Kaelin Jr W . Chemosensitivity linked to p73 function. Cancer Cell. 2003; 3(4):403-10. DOI: 10.1016/s1535-6108(03)00078-3. View